Process Engineering STREAM
-
Accelerating Novel Cell Therapies To Market
3/20/2024
Learn about two matrices that, when combined, provide an optimal solution for the process development and manufacturing of novel induced pluripotent stem cell therapies.
-
It's Time To Intensify
8/7/2025
The biopharmaceutical industry is evolving fast, which is pushing manufacturers to cut costs and boost productivity. Discover how process intensification can streamline operations and secure your future.
-
E&L Testing And 3D Printed Single-Use Parts
7/29/2026
Bioprocess scientists may not be experts in polymer chemistry. That means getting support from resin and equipment manufacturers when conducting extractables and leachables testing.
-
Addressing Manufacturability And Scalability Challenges In Multispecifics Purification
6/2/2025
In this final segment from the Bioprocess Online Live event, “Challenges And Considerations For Purifying Multispecific Molecules,” our panelists answer some remaining audience questions relating to viral inactivation, affinity resins, precipitation steps in purification, and downstream scalability challenges.
-
Navigating The Workflow From Process Development To GMP Manufacturing For Making Clonal iPSC-Derived Master Cell Banks
3/7/2022
In this video, we present data for optimizing choices of which combinations of GMP-compatible matrix, dissociation reagents, and media can best be employed for single cell cloning of iPSCs in process development.
-
DynaDrive S.U.B. Video Series
4/1/2026
Explore DynaDrive Single-Use Bioreactors through expert videos covering reactor design, mixing performance, sparge technology, and scalable workflows from bench-scale to commercial production.
-
Inside Bioprocessing: Microbial Media
11/4/2025
Learn the reasons why the animal origin-free trend in bioprocessing has taken so long to reach microbial bioproduction and the technical hurdles overcome during the development of Gibco CD Bacto Supreme.
-
Perfusion: Planning A Run
6/16/2025
Learn about a logical approach for defining the operation of a perfusion run. We will break down the process using the three following steps: knowledge space, design space, and control space.
-
Maintaining Downstream Quality In Multi-Specific Antibody Manufacturing
8/9/2023
Bayer Sr. Director, Bioprocess Technologies, Amir Goudarzi, Ph.D., addresses audience questions on downstream multi-specific mAb processing challenges, specifically purification in terms of CPP and QRA, and microbial or thermal degradation, in this segment of the Bioprocess Online Live event, Process Development For A Diverse mAb Pipeline.
-
Collaborating For A Sustainable Future
10/3/2025
Explore how cross-industry partnerships are driving sustainable process intensification to enable faster innovation, reduced waste, and long-term progress through shared goals and scalable solutions.